4.2 Review

Cognitive Deficits as a Mediator of Poor Occupational Function in Remitted Major Depressive Disorder Patients

Journal

CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE
Volume 14, Issue 1, Pages 1-16

Publisher

KOREAN COLL NEUROPSYCHOPHARMACOLOGY
DOI: 10.9758/cpn.2016.14.1.1

Keywords

Depression; Remission; Cognition; Occupational outcome

Funding

  1. Lundbeck
  2. Astra Zeneca
  3. Pfizer
  4. Shire
  5. Otsuka
  6. Bristol Myers Squibb
  7. National Institute of Mental Health
  8. Stanley Medical Research Institute
  9. Canadian Institutes for Health Research
  10. Brain and Behavior Research Foundation
  11. Elli Lilly
  12. Janssen Ortho
  13. Sunovion
  14. Forest
  15. Takeda

Ask authors/readers for more resources

Cognitive deficits in major depressive disorder (MDD) patients have been described in numerous studies. However, few reports have aimed to describe cognitive deficits in the remitted state of MDD and the mediational effect of cognitive deficits on occupational outcome. The aim of the current review is to synthesize the literature on the mediating and moderating effects of specific domains of cognition on occupational impairment among people with remitted MDD. In addition, predictors of cognitive deficits found to be vocationally important will be examined. Upon examination of the extant literature, attention, executive function and verbal memory are areas of consistent impairment in remitted MDD patients. Cognitive domains shown to have considerable impact on vocational functioning include deficits in memory, attention, learning and executive function. Factors that adversely affect cognitive function related to occupational accommodation include higher age, late age at onset, residual depressive symptoms, history of melancholic/psychotic depression, and physical/psychiatric comorbidity, whereas higher levels of education showed a protective effect against cognitive deficit. Cognitive deficits are a principal mediator of occupational impairment in remitted MDD patients. Therapeutic interventions specifically targeting cognitive deficits in MDD are needed, even in the remitted state, to improve functional recovery, especially in patients who have a higher risk of cognitive deficit.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available